Mitochondrial Diseases Caused by Toxic Compound Accumulation: from Etiopathology to Therapeutic Approaches

Overview

Journal EMBO Mol Med

Specialty Molecular Biology

Date 2015 Jul 22

PMID 26194912

Citations 23

Authors

Ivano Di Meo

Costanza Lamperti

Valeria Tiranti

Affiliations

Soon will be listed here.

Abstract

Mitochondrial disorders are a group of highly invalidating human conditions for which effective treatment is currently unavailable and characterized by faulty energy supply due to defective oxidative phosphorylation (OXPHOS). Given the complexity of mitochondrial genetics and biochemistry, mitochondrial inherited diseases may present with a vast range of symptoms, organ involvement, severity, age of onset, and outcome. Despite the wide spectrum of clinical signs and biochemical underpinnings of this group of dis-orders, some common traits can be identified, based on both pathogenic mechanisms and potential therapeutic approaches. Here, we will review two peculiar mitochondrial disorders, ethylmalonic encephalopathy (EE) and mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), caused by mutations in the ETHE1 and TYMP nuclear genes, respectively. ETHE1 encodes for a mitochondrial enzyme involved in sulfide detoxification and TYMP for a cytosolic enzyme involved in the thymidine/deoxyuridine catabolic pathway. We will discuss these two clinical entities as a paradigm of mitochondrial diseases caused by the accumulation of compounds normally present in traces, which exerts a toxic and inhibitory effect on the OXPHOS system.

Citing Articles

Engineered mitochondria in diseases: mechanisms, strategies, and applications.

Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.

PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.

Targeting mitochondria with antioxidant nutrients for the prevention and treatment of postweaning diarrhea in piglets.

Qiao L, Dou X, Song X, Chang J, Yi H, Xu C Anim Nutr. 2023; 15:275-287.

PMID: 38033610 PMC: 10685042. DOI: 10.1016/j.aninu.2023.09.002.

Disruption of Bioenergetics in the Intestine of Wistar Rats Caused by Hydrogen Sulfide and Thiosulfate: A Potential Mechanism of Chronic Hemorrhagic Diarrhea in Ethylmalonic Encephalopathy.

Frusciante M, Signori M, Parmeggiani B, Grings M, Pramio J, Cecatto C Cell Biochem Biophys. 2023; 81(4):683-695.

PMID: 37589888 DOI: 10.1007/s12013-023-01161-0.

Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies.

Lin H, Yu Y, Zhu L, Lai N, Zhang L, Guo Y Redox Biol. 2023; 59:102601.

PMID: 36630819 PMC: 9841368. DOI: 10.1016/j.redox.2023.102601.

Mitochondrial biology and dysfunction in secondary mitochondrial disease.

Baker M, Crameri J, Thorburn D, Frazier A, Stojanovski D Open Biol. 2022; 12(12):220274.

PMID: 36475414 PMC: 9727669. DOI: 10.1098/rsob.220274.

References

Kimura Y, Kimura H . Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004; 18(10):1165-7. DOI: 10.1096/fj.04-1815fje. View

Kamoun P . Endogenous production of hydrogen sulfide in mammals. Amino Acids. 2004; 26(3):243-54. DOI: 10.1007/s00726-004-0072-x. View

Giordano C, Viscomi C, Orlandi M, Papoff P, Spalice A, Burlina A . Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis. 2011; 35(3):451-8. DOI: 10.1007/s10545-011-9408-3. View

Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C . Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med. 2009; 15(2):200-5. DOI: 10.1038/nm.1907. View

Viscomi C, Burlina A, Dweikat I, Savoiardo M, Lamperti C, Hildebrandt T . Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med. 2010; 16(8):869-71. DOI: 10.1038/nm.2188. View

Ferdinandy P, Schulz R, Baxter G . Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007; 59(4):418-58. DOI: 10.1124/pr.107.06002. View

Lopez-Contreras A, Specks J, Barlow J, Ambrogio C, Desler C, Vikingsson S . Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice. Genes Dev. 2015; 29(7):690-5. PMC: 4387711. DOI: 10.1101/gad.256958.114. View

Xu M, Wu Y, Li Q, Wang X, He R . Electrophysiological effects of hydrogen sulfide on pacemaker cells in sinoatrial nodes of rabbits. Sheng Li Xue Bao. 2008; 60(2):175-80. View

Lopez L, Akman H, Garcia-Cazorla A, Dorado B, Marti R, Nishino I . Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet. 2008; 18(4):714-22. PMC: 2638828. DOI: 10.1093/hmg/ddn401. View

10.

Moran N, Bain M, Muqit M, Bax B . Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology. 2008; 71(9):686-8. DOI: 10.1212/01.wnl.0000324602.97205.ab. View

11.

Samuelson J . Why metronidazole is active against both bacteria and parasites. Antimicrob Agents Chemother. 1999; 43(7):1533-41. PMC: 89320. DOI: 10.1128/AAC.43.7.1533. View

12.

Boschetti E, DAlessandro R, Bianco F, Carelli V, Cenacchi G, Pinna A . Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS One. 2014; 9(5):e96692. PMC: 4011889. DOI: 10.1371/journal.pone.0096692. View

13.

Yalamanchili C, Smith M . Acute hydrogen sulfide toxicity due to sewer gas exposure. Am J Emerg Med. 2008; 26(4):518.e5-7. DOI: 10.1016/j.ajem.2007.08.025. View

14.

Delicou S, Kitra-Roussou V, Peristeri J, Goussetis E, Vessalas G, Rigatou E . Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency. Pediatr Transplant. 2007; 11(7):799-803. DOI: 10.1111/j.1399-3046.2007.00772.x. View

15.

Wallace D . A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005; 39:359-407. PMC: 2821041. DOI: 10.1146/annurev.genet.39.110304.095751. View

16.

Pedersen C, Bross P, Winter V, Corydon T, Bolund L, Bartlett K . Misfolding, degradation, and aggregation of variant proteins. The molecular pathogenesis of short chain acyl-CoA dehydrogenase (SCAD) deficiency. J Biol Chem. 2003; 278(48):47449-58. DOI: 10.1074/jbc.M309514200. View

17.

Hirano M, Garone C, Quinzii C . CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim Biophys Acta. 2012; 1820(5):625-31. PMC: 3319470. DOI: 10.1016/j.bbagen.2012.01.006. View

18.

Nishino I, Spinazzola A, Hirano M . Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999; 283(5402):689-92. DOI: 10.1126/science.283.5402.689. View

19.

Klentz R, Fedde M . Hydrogen sulfide: effects on avian respiratory control and intrapulmonary CO2 receptors. Respir Physiol. 1978; 32(3):355-67. DOI: 10.1016/0034-5687(78)90123-8. View

20.

Burlina A, Zacchello F, Dionisi-Vici C, Bertini E, Sabetta G, Bennet M . New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet. 1991; 338(8781):1522-3. DOI: 10.1016/0140-6736(91)92338-3. View